ScholarIQanswers from OpenAlex
Diabetes, Cardiovascular Risks, and Lipoproteins
TopicLeading institutions, researchers & key papers
Diabetes, Cardiovascular Risks, and Lipoproteins is a topic indexed in ScholarIQ from OpenAlex.
What is known about Diabetes, Cardiovascular Risks, and Lipoproteins?
ScholarIQrecord summary
This cluster of papers focuses on the metabolic syndrome, its association with cardiovascular disease, diabetes, insulin resistance, obesity, and atherosclerosis. It includes studies on glucose metabolism, lifestyle interventions, and global prevalence of related conditions.
How many works does Diabetes, Cardiovascular Risks, and Lipoproteins have?
ScholarIQindexed works
Diabetes, Cardiovascular Risks, and Lipoproteins has 1,085 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Diabetes, Cardiovascular Risks, and Lipoproteins?
ScholarIQopenalex
The OpenAlex for Diabetes, Cardiovascular Risks, and Lipoproteins is on the source record.
What are the most-cited papers on Diabetes, Cardiovascular Risks, and Lipoproteins?
ScholarIQmost cited works
Diagnosis and Management of the Metabolic Syndrome
Scott M. Grundy, James I. Cleeman, Stephen R. Daniels, Karen A. Donato, Robert H. Eckel, Barry A. Franklin, David J. Gordon, Ronald M. Krauss, Peter J. Savage, Sidney C. Smith, John A. Spertus, Fernando Costa
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A. Motala, Katherine Ogurtsova, Jonathan E. Shaw, Dominic Bright, Rhys Williams
Effects of Intensive Glucose Lowering in Type 2 Diabetes
The Action to Control Cardiovascular Risk in Diabetes Study Group
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Katherine Ogurtsova, João Diogo da Rocha Fernandes, Yadi Huang, Ute Linnenkamp, Leonor Guariguata, N.H. Cho, David Cavan, Jonathan E. Shaw, Lydia Makaroff
Heart Disease and Stroke Statistics—2016 Update
Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go, Donna K. Arnett, Michael J. Blaha, Mary Cushman, Sandeep R. Das, Sarah D. de Ferranti, Jean‐Pierre Després, Heather J. Fullerton, Virginia J. Howard, Mark D. Huffman, Carmen R. Isasi, Monik C. Jiménez, Suzanne E. Judd, Brett Kissela, Judith H. Lichtman, Lynda D. Lisabeth, Simin Liu, Rachel H. Mackey, David J. Magid, Darren K. McGuire, Emile R. Mohler, Claudia S. Moy, Paul Muntner, Michael E. Mussolino, Khurram Nasir, Robert W. Neumar, Graham Nichol, Latha Palaniappan, Dilip K. Pandey, Mathew J. Reeves, Carlos J. Rodríguez, Wayne D. Rosamond, Paul D. Sorlie, Joel Stein, Amytis Towfighi, Tanya N. Turan, Salim S. Virani, Daniel Woo, Robert W. Yeh, Melanie B. Turner
Where is Diabetes, Cardiovascular Risks, and Lipoproteins research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Diabetes, Cardiovascular Risks, and Lipoproteins is open access?
ScholarIQopen access share
60%OPEN ACCESS